Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

40 results
Display

A Public-Private Collaboration Model for Treatment Intervention to Improve Outcomes in Patients with Tuberculosis in the Private Sector

Kim HJ, Bai GH, Kang MK, Kim SJ, Lee JK, Cho SI, Lew WJ

BACKGROUND: The treatment success rates in patients with tuberculosis are known to be lower in the private sector compared to the public sector. To improve treatment outcomes in the private...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of the Broth Microdilution Method Using 2,3-Diphenyl-5-thienyl-(2)-tetrazolium Chloride for Rapidly Growing Mycobacteria Susceptibility Testing

Lee SM, Kim JM, Jeong J, Park YK, Bai GH, Lee EY, Lee MK, Chang CL

As the incidence of nontuberculous mycobacterial infection has been increasing recently in Korea, the importance of drug susceptibility test for clinical isolates of mycobacteria has become larger. In this study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pulmonary Disease Caused by Mycobacterium xenopi: The First Case in Korea

Park HY, Koh WJ, Kwon OJ, Lee NY, Shim YM, Park YK, Bai GH, Mun HS, Kim BJ

Mycobacterium xenopi is a nontuberculous mycobacterium (NTM) that rarely causes pulmonary disease in Asia. Here we describe the first case of M. xenopi pulmonary disease in Korea. A 66-year-old man...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug Resistance Rates of Mycobacterium tuberculosis at a Private Referral Center in Korea

Choi JC, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Lee NY, Park YK, Bai GH, Koh WJ

The goals of this study were to identify first-line drug resistance in new and previously treated tuberculosis (TB) cases and to determine risk factors for multidrugresistant TB (MDR-TB) at a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Interval Between Initiation of Anti-tuberculosis Treatment in Patients with Culture-positive Pulmonary Tuberculosis and Receipt of Drug-susceptibility Test Results

Joh JS, Lee CH, Lee JE, Park YK, Bai GH, Kim EC, Han SK, Shim YS, Yim JJ

Although mycobacterial culture and the subsequent drug-susceptibility test (DST) for anti-tuberculosis (TB) drugs take several months to complete using solid media, there are no reports on the turnaround times of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of Automatic Acid-Fast Bacilli Stainer AT-2000F

Kim SY, Yang EK, Kim YJ, Lee SM, Lee EY, Park YK, Bai GH, Chang CL

  • KMID: 2224723
  • Korean J Clin Microbiol.
  • 2006 Oct;9(2):115-118.
BACKGROUND: Sputum smear microscopy is rapid, economic, and useful to detect patients with transmittable tuberculosis, albeit laborious. We aimed to evaluate the usefulness of an automated acid-fast bacilli stainer, which...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Current Status of Multidrug-resistant Tuberculosis in Korea

Kim BJ, Lee IH, Lee DH, Bai GH, Kong SJ, Lee SH, Moon HR, Lee KR, Lee JY, Park SK

PURPOSE: Multidrug-resistant tuberculosis (MDR-TB) is an emerging threat to human beings. However, there is little data on the current status of MDR-TB in Korea. This study investigated the current status...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of DNA fingerprints of Mycobacterium Tuberculosis Isolates from Patients Registered at Health Center in Gyeonggi Province in 2004

Park YK, Kang HY, Lim JG, Ha JS, Cho JO, Lee KC, Choi HS, Choi YH, Sheen SS, Bai GH

  • KMID: 2318843
  • Tuberc Respir Dis.
  • 2006 Mar;60(3):290-296.
BACKGROUND: IS6110 DNA fingerprint is a very useful tool for investigating the transmission of tuberculosis. The aim of this study was to identify the epidemiological situations within a given area...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Investigation of the Growth Rate Change in Recombinant BCG which was cloned Mycobacterium tuberculosis Adenylate Kinase Mutation Gene or Human Muscle-type Adenylate Kinase Synthetic Gene

Lee SH, Kim HJ, Park YK, Bai GH

  • KMID: 2318818
  • Tuberc Respir Dis.
  • 2006 Feb;60(2):187-193.
BACKGROUND: Normal cell proliferation and viability is strongly depends on the availability of metabolic energy and the maintenance of the appropriate adenylate-nucleotide pools. Hypothetically, changes in adenylate kinase (AK) expression...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Trend in Acquired Drug Resistances of Tuberculosis Patients Registered in Health Centers from 1981 to 2004

Chang CL, Lee EY, Park SK, Jeong SH, Park YK, Choi YW, Kim HJ, Lew WJ, Bai GH

  • KMID: 2318747
  • Tuberc Respir Dis.
  • 2005 Dec;59(6):619-624.
BACKGROUND: The drug resistance rate in tuberculosis patients with history of chemotherapy is an important indicator of for evaluation of appropriateness of treatment regimens and compliance of patients. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mycobacterium kansasii Pulmonary Diseases in Korea

Yim JJ, Park YK, Lew WJ, Bai GH, Han SK, Shim YS

Mycobacterium kansasii is one of the most common cause of pulmonary diseases due to nontuberculous mycobacteria. We investigated the changing in the number of isolation of M. kansasii and the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Implication of embB Gene Mutation in Ethambutol-Susceptible Clinical Isolates of Mycobacterium tuberculosis

Park YK, Shin S, Kim SJ, Koh WJ, Kwon OJ, Kim BJ, Kook YH, Cho SN, Lew WJ, Bai GH

  • KMID: 2318663
  • Tuberc Respir Dis.
  • 2005 Sep;59(3):266-271.
BACKGROUND: Ethambutol(EMB) is one of the first-line drugs included in short-course anti-tuberculosis therapy. The point mutations in embB gene have been speculated to be associated EMB resistance. However, detection of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Proportion of Rifabutin-susceptible Strains among Rifampicin- resistant Isolates and Its Specific rpoB Mutations

Lew WJ, Park YK, Kim HJ, Chang C, Bai GH, Kim SK

  • KMID: 2318662
  • Tuberc Respir Dis.
  • 2005 Sep;59(3):257-265.
BACKGROUND: Rifabutin (ansamycin) is a spiro-piperidyl rifamycin, which is highly active against Mycobacterium tuberculosis. It has been found that some clinical isolates of tubercle bacilli that are resistant to rifampicin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cross Resistance of Fluoroquinolone Drugs on gyrA Gene Mutation in Mycobacterium tuberculosis

Park YK, Park CH, Koh WJ, Kwon OJ, Kim BJ, Kook YH, Cho SN, Chang CH, Bai GH

  • KMID: 2318661
  • Tuberc Respir Dis.
  • 2005 Sep;59(3):250-256.
BACKGROUND: Fluoroquinolone drugs are an important anti-tuberculous agent for the treatment of multi-drug resistant tuberculosis. However, many drugs belonging to the fluoroquinolones have different cross resistance to each other. METHODS: Sixty-three...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Protective Efficacy of Recombinant Proteins Adenylate Kinase, Nucleoside Diphosphate Kinase, and Heat-Shock Protein 70 against Mycobacterium tuberculosis Infection in Mice

Lee SH, Lee EG, Kim SY, Cho SN, Park YK, Bai GH

  • KMID: 2318536
  • Tuberc Respir Dis.
  • 2005 Feb;58(2):142-151.
BACKGROUND: Priming and boosting vaccination strategy has been widely explored for new vaccine development against tuberculosis. As an effort to identify other vaccine candidates, this study was initiated to evaluate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Detection of embB Gene Mutation of Mycobacterium tuberculosis by Reverse Hybridization Assay

Park YK, Yu HK, Park CH, Ryu SW, Lee SH, Shim MS, Lew WJ, Koh WJ, Kwon OJ, Cho SN, Bai GH

  • KMID: 2318534
  • Tuberc Respir Dis.
  • 2005 Feb;58(2):129-134.
BACKGROUND: Ethambutol (EMB) is one of important first-line drug in the treatment of tuberculosis. Molecular techniques to detect embB gene mutations have been considered as an method to define the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multi-center Study on Cost Effectiveness of Anti-Tuberculosis Drug Susceptibility Test

Jeong SH, Lee DD, Choi JC, Kim S, Shin JH, Jeong J, Lee EY, Oh SH, Bai GH, Chang CL

  • KMID: 2285097
  • Infect Chemother.
  • 2005 Feb;37(1):16-21.
BACKGROUND: The anti-mycobacterial susceptibility test is performed on only a small percentage of clinical isolates in Korea. The aim of this study is to propose an anti-mycobacterial susceptibility testing scheme,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Mycobacterium avium Complex (MAC) Pulmonary Disease

Koh WJ, Kwon OJ, Kang EH, Suh GY, Chung MP, Kim H, Chung MJ, Kim TS, Lee KS, Lee NY, Park YK, Bai GH

BACKGROUND: There has been a gradual increase in the number of newly diagnosed cases of Mycobacterium avium complex (MAC) pulmonary disease. However, the optimal therapeutic regimen for the disease has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Construction of Recombinant BCGs Overexpressing Antigen 85 Complex and Their Protective Efficacy against Mycobacterium tuberculosis Infection in a Mouse Model

Lee SH, Jeon BY, Park YG, Lee HY, Cho SN, Kim HJ, Bai GH

Tuberculosis (TB) remains an enormous global health problem, and a new vaccine against TB more potent than the current inadequate BCG vaccine is urgently needed. We constructed three recombinant Mycobacterium...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Molecular Taxonomic Survey of Mycobacteria Clinical Isolates from Patients in Jeju Island by rpoB Gene Based Molecular Biological Methods

Kim H, Kim SH, Bai GH, Park YG, Cha CY, Kook YH, Kim BJ

  • KMID: 2055003
  • J Bacteriol Virol.
  • 2004 Jun;34(2):113-119.
The rpoB gene based sequencing analysis enabled not only the detection of rifampin resistant Mycobacterium tuberculosis, but also the differentiation of species in the genus Mycobacterium. In the present study,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr